Edition:
United Kingdom

Eagle Pharmaceuticals Inc (EGRX.OQ)

EGRX.OQ on NASDAQ Stock Exchange Global Market

54.94USD
20 Apr 2018
Change (% chg)

-- (--)
Prev Close
$54.94
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
97,546
52-wk High
$97.14
52-wk Low
$45.05

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month		 Last Updated
Outperform 1.00 December 24 Apr 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago		 2 Month
Ago		 3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 2 2 2 2
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 1 1 1 1
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.25 2.25 2.25 2.25

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 4 50.79 55.15 47.00 66.70
Quarter Ending Sep-18 4 50.05 51.20 47.39 86.00
Year Ending Dec-18 4 201.06 205.70 189.90 268.96
Year Ending Dec-19 4 220.98 235.80 210.30 343.83
Earnings (per share)
Quarter Ending Jun-18 4 1.00 1.08 0.92 1.19
Quarter Ending Sep-18 4 0.96 1.15 0.75 1.78
Year Ending Dec-18 4 3.70 4.06 3.27 4.30
Year Ending Dec-19 4 4.18 4.53 3.96 6.48

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Dec-17 52.91 46.78 6.12 11.58
Quarter Ending Sep-17 51.86 63.02 11.16 21.53
Quarter Ending Jun-17 52.52 50.11 2.41 4.59
Quarter Ending Mar-17 70.37 76.79 6.42 9.12
Quarter Ending Dec-16 85.95 81.14 4.81 5.60
Earnings (per share)
Quarter Ending Dec-17 1.00 1.00 0.00 0.50
Quarter Ending Sep-17 0.80 1.22 0.42 52.98
Quarter Ending Jun-17 0.51 0.28 0.23 45.10
Quarter Ending Mar-17 1.41 1.42 0.00 0.35
Quarter Ending Dec-16 2.82 3.52 0.70 24.93

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago		 1 Month
Ago		 2 Month
Ago		 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 50.79 51.02 51.43 57.15 66.70
Quarter Ending Sep-18 50.05 50.21 49.88 56.75 86.00
Year Ending Dec-18 201.06 203.07 204.25 211.40 268.96
Year Ending Dec-19 220.98 223.43 224.08 223.93 343.83
Earnings (per share)
Quarter Ending Jun-18 1.00 0.99 1.01 1.33 1.19
Quarter Ending Sep-18 0.96 0.92 0.89 1.40 1.78
Year Ending Dec-18 3.70 3.73 3.78 4.64 4.30
Year Ending Dec-19 4.18 4.20 4.19 4.36 6.48

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-18 0 1 0 1
Quarter Ending Sep-18 0 1 0 1
Year Ending Dec-18 0 1 0 2
Year Ending Dec-19 0 1 0 2
Earnings
Quarter Ending Jun-18 1 0 1 0
Quarter Ending Sep-18 1 0 1 0
Year Ending Dec-18 0 1 0 2
Year Ending Dec-19 0 1 1 1

Earnings vs. Estimates

» More Financials

Eagle Pharmaceuticals Inc News

» More EGRX.OQ News